Ferrous sulfate with folic acid
Brand names: Ferrograd Folic, Slow-Fe Folic
This combination of ferrous sulfate with folic acid is used mainly for the prevention of iron and folate deficiency in pregnancy.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Ferrous sulfate supplies absorbable iron for haemoglobin synthesis, while folic acid provides the folate required for DNA synthesis and normal red cell maturation, together supporting erythropoiesis and neural tube development.
Prescribing in practice
- The folic acid dose in these prophylactic combinations is intended for prevention and is insufficient for established megaloblastic anaemia or for high-risk neural tube defect prophylaxis, which require dedicated higher-dose folic acid.
- Folic acid can mask the haematological signs of vitamin B12 deficiency while allowing neurological damage to progress, so exclude B12 deficiency before relying on folate alone.
- Standard iron absorption interactions apply, so separate from tea, antacids, calcium and chelated drugs such as tetracyclines and levothyroxine.
Monitoring
Monitor haemoglobin during pregnancy and review the formulation if treatment of an established anaemia rather than prophylaxis is required.
Counselling the patient
- This product is for preventing iron and folate deficiency, usually in pregnancy.
- Stools may turn black, which is harmless.
- Keep out of reach of children because of iron overdose risk.
Evidence & guidelines
NICE advises folic acid supplementation before and in early pregnancy to reduce neural tube defect risk, with combination iron-folate products used for routine antenatal prophylaxis.
Reference: NICE CG62; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Corrected Reticulocyte Count / Reticulocyte Production Index · Anaemia
- Ganzoni Equation for Iron Deficiency · Anaemia
- Transferrin Saturation Calculator · Anaemia / Iron Studies
- Tumor Lysis Syndrome Risk (Cairo-Bishop) · Oncological Emergency
- Iron Deficiency Anaemia Calculator · Anaemia Assessment
- Ferritin Iron Store Interpretation · Haematological Values
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Anaemia Investigation · BSH / NICE
- Splenomegaly Workup · BSH; BMJ Best Practice
- Deep Vein Thrombosis Diagnosis and Treatment · NICE CG144 / NICE NG158
- Sickle Cell Crisis · BSH 2021 / BCSH
- Neutropenic Sepsis · NICE CG151 2012 / ESMO